Scanned image of the page. Keyboard directions: use + to zoom in, - to zoom out, arrow keys to pan inside the viewer.

Page Options


Something wrong?

Something wrong with this page? Report problem.

Rights / Permissions

The University of Michigan Library provides access to these materials for educational and research purposes. These materials may be under copyright. If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission. If you have questions about the collection, please contact the Bentley Historical Library at bentley.ref@umich.edu

May 24, 2007 - Image 11

Resource type:
The Detroit Jewish News, 2007-05-24

Disclaimer: Computer generated plain text may have errors. Read more about this.


A New FDA Cleared Medical Device, the
DRX 9000 Decompression System, provides
for the non-surgical management of pain and
disability for patients suffering with incapaci-
tating low back pain and sciatica.

86% effectiveness in treating
patients with herniated and degenerative

The DRX 9000 has been found to provide
relief of pain and symptoms associated with

The DRX 9000 has clinically demonstrated
in our practice to significantly reduce or elimi-
nate pain, avoid surgery, and reduce medica-

A recent Clinical Study Demonstrated

disc disease**

herniated discs, bulging or protruding intraver-

tebral discs, degenerative disc disease, posterior tion in most of our practice's patients, allowing
them to return to their normal activities and
facet syndrome, and sciatica!
pain-free living within weeks.

"I was diagnosed with four bulging discs. Two weeks ago,
before I started care at HealthQuest, I had severe pain
and difficulty doing everything. I can't believe that after
only two weeks, I have more energy and feel great. It is
definitely worth the 60 mile round trip and I would
recommend this to anyone who suffers like I did."

— Sharon K, Si. Clair, MI

certify that these quotes are unsolicited true statements and the patient
was not paid for this statement. Dr. Sol Cogan



Dr. Sol Cogan

*FDA 510(k) — Division of General, Restorative and Neurological Devices
m • ression by Thomas A. Gionis, MD, JD, MBA, MHA, FIGS, FRCS, and Eric Groeke, DC, CC

Back to Top

© 2021 Regents of the University of Michigan